Ascierto, Paolo A. http://orcid.org/0000-0002-8322-475X
Brugarolas, James
Buonaguro, Luigi
Butterfield, Lisa H.
Carbone, David
Daniele, Bruno
Ferris, Robert
Fox, Bernard A.
Galon, Jérôme
Gridelli, Cesare
Kaufman, Howard L.
Klebanoff, Christopher A.
Melero, Ignacio
Nathan, Paul
Paulos, Chrystal M.
Ruella, Marco
Sullivan, Ryan
Zarour, Hassane
Puzanov, Igor
Article History
Received: 22 March 2018
Accepted: 19 June 2018
First Online: 11 July 2018
Ethics approval and consent to participate
: Not applicable
: Not applicable
: Paolo A. Ascierto (PAA): Consultant/Advisory Role: Bristol-Meyers Squibb, Roche-Genentech, Merck Sharp & Dohme, Novartis, Amgen, Array, Merck Serono, Pierre-Fabre, Incyte, NewLink Genetics, Genmab, Medimmune; Research Funding: Bristol-Meyers Squibb, Roche-Genentech, Array.James Brugarolas (JB): Consultant: Bethyl Laboratories, Nektar; Research Funding: Genentech, Peloton Therapeutics.David Carbone (DC): Consultant: Abbvie, Adaptimmune, Agenus, Amgen, Ariad, AstraZeneca, Biocept, Boehringer Ingelheim, Bristol Myers-Squibb (BMS), Celgene, Foundation Medicine, Genentech/Roche, Gritstone, Guardant Health, Inovio, Merck, MSD, Novartis, Palobiofarma, Pfizer, prIME Oncology, Stemcentrx, Takeda; Grant Funding: Bristol Myers-Squibb (BMS).Bruno Daniele (BD): Funding from Bayer, Bristol-Myers Squibb (BMS), MSD, Lilly.Robert Ferris (RF): Astra-Zeneca/MedImmune: Advisory Board, Clinical trial, Research Funding; Bristol-Myers Squibb: Advisory Board, Clinical Trial, Research Funding; Lilly: Advisory Board; Merck: Advisory Board, Clinical Trial; Pfizer: Advisory Board; VentiRx Pharmaceuticals: Research Funding; Tesaro: Research Funding.Bernard A. Fox (BAF): Scientific Advisory Board: Argos, Bayer, Bristol-Myers Squibb, CellDex Therapeutics, Clearlight, Definiens, Immunophotonics, Janssen/Johnson & Johnson, MedImmune/AstraZeneca, PerkinElmer, Peregrine, PrimeVax, UbiVac, co-founder/Managing Member, Ventana/Roche. Research Support: Aduro, Bayer, Bristol-Myers Squibb, Definiens, Janssen/Johnson & Johnson, MedImmune/AstraZeneca, OncoSec, PerkinElmer, Quanterix, Shimadzu, Ventana/Roche, Viralytics.Jerome Galon (JC): Co-founder and chairman of the scientific advisory board: HalioDx; Collaborative Research Agreement (grants): Perkin-Elmer, IObiotech, MedImmune, Janssen; Participation to Scientific Advisory Boards: BMS, MedImmune, Astra Zeneca, Novartis, Definiens, Merck Serono, IObiotech, ImmunID, Nanostring, Illumina, Northwest Biotherapeutics, Actelion, Amgen, Kite Pharma; Consultant: BMS, Roche, GSK, Compugen, Mologen.Cesare Gridelli (CG): Funding from MSD, BMS, Roche, Astra Zeneca.Howard L. Kaufman (HLK): Replimune, Inc.Ignacio Melero (IM): Advisory role: Bristol Myers, AstraZeneca, Roche Genentech, Alligator, Bioncotech, Bayer, F-Star, Genmab, Lilly. Speaker Bureau: Merck, Bristol Myers. Research grants: BMS, Roche-Genentech.Paul Nathan (PN): Advisory Board: AZ, BMS, Immunocore, Ipsen, Incyte, MSD, Merck, Novartis, Pfizer, Pierre Fabre, Roche.Igor Puzanov (IP): Consultant: Amgen, Hoffmann-La Roche; Clinical Trial Support: Merck, Amgen, Plexxikon, Hoffmann-La Roche, GlaxoSmithKline, Bristol Myers SquibbMarco Ruella (MR): CART technologies, Univ. of Pennsylvania, licensed to Novartis, Inventor. Novartis, Tmunity Research Support.Ryan J. Sullivan (RJS): advisor for Merck, Genetech, and NovartisHassane Zarour (HZ): Research Contracts From BMS , Merck and Tesaro. Advisory Board: Pierre Fabre, Curis.Luigi Buonaguro (LB), Lisa H. Butterfield (LHB), Christoper A. Klebanoff (CAK), Chrystal M. Paulos (CMP) declare no relevant conflicts of interest to report.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.